Here are relevant reports on : fund-administration-market
-
Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Device (Insulin, Syringe, Volumetric, Enteral, PCA Pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031
The Europe infusion pump market, valued at USD 4.78 billion in 2025, stood at USD 5.10 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Pediatric Vascular Access Market by Type (Catheters (CVC, PIVC, PICC), Ports, IV Sets, Infusion Pumps), Application (Drug Administration, Blood Transfusion, Diagnostics & Testing), End User (Hospitals, ASCs) - Global Forecast to 2030
The global pediatric vascular access market, valued at US$0.51 billion in 2023, stood at US$0.54 billion in 2024 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$0.83 billion by the end of the period. The market for pediatric vascular access is driven by the increasing prevalence of preterm births, and advancements in pediatric care technologies are key factors fueling the growth of the pediatric vascular access market.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
North America Vaccines Market by Technology (Conjugate, Recombinant, Inactivated, Live Attenuated, Viral Vector), Type (Monovalent, Multivalent), Disease (Pneumococcal, Flu, Hepatitis, MMR), Route of Administration (IM, SC, Oral) - Forecast to 2030
The North America vaccines market, valued at US$25.95 billion in 2024, stood at US$25.29 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$35.68 billion by the end of the period. The vaccines market is growing rapidly, driven by swift global vaccine development and commercialization, higher rates of infectious diseases necessitating preventive vaccines, expanded immunization initiatives, innovations in vaccine technology, and increased government funding and investments for novel vaccines against diverse diseases.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Identity and Access Management (IAM) Market by Solution, Service, Technology [Access Management, Identity Governance & Administration (IGA), Privileged Access Management (PAM)], Type (Workforce, CIAM, B2B), Identity Type - Forecast to 2030
The identity and access management (IAM) market in the Asia Pacific region is projected to grow from USD 5.29 billion in 2025 to USD 9.55 billion by 2030, at a CAGR of 12.5% over the forecast period. Microsoft (US), IBM (US), Okta (US), Oracle (US Ping Identity (US), CyberArk (US), HID Global (US), NuSummit Cybersecurity (Aujas) (India), WSO2 (US), Wipro (India), Signzy (India), miniOrange (India), RSA Security (US), Delinea (US), ManageEngine (US), One Identity (US), and Auth0 (US) are the key players and other major players in the IAM market in Asia Pacific.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Veterinary Vaccines Market by Type (Porcine, Poultry, Livestock, Companion Animals), Technology (Live Attenuated, Inactivated, Toxoid), Route of Administration (Intramuscular, Subcutaneous, Oral), and End User (Hospitals, Clinics) – Forecast to 2031
The Europe veterinary vaccines market, valued at USD3.84 billion in 2025, stood at USD4.08 billion in 2026 and is projected to advance at a resilient CAGR of 6.6% from 2026 to 2031, culminating in a forecasted valuation of USD5.61 billion by the end of the period. The growth of the market is driven by the increased pet ownership and greater emphasis on animal welfare.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Middle East & Africa Pharmaceutical Drug Delivery Market by Route of Administration (Injectable [Syringe, Auto injector], Oral [Tablet, Capsule, Syrup], Topical, Nasal, Ocular, Rectal), Application (Cancer, Diabetes, CVD, Ophthalmic) - Forecast to 2031
The Middle East & Africa Pharmaceutical Drug Delivery market, valued at USD 37.39 billion in 2025, stood at USD 38.20 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 48.22 billion by the end of the period. The Middle East & Africa pharmaceutical drug delivery market is expanding steadily due to the modernization of healthcare infrastructure and the growing adoption of patient-friendly treatment modalities.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Consumer Identity and Access Management (CIAM) Market by Solutions (Identity Administration, PII Management & Analytics, Access Management, Fraud Detection), Services, Authentication Type, and Vertical - Global Forecast to 2030
The global Consumer IAM market size is projected to grow from USD 14.12 billion in 2025 to USD 22.47 billion by 2030 at a Compound Annual Growth Rate (CAGR) of 9.7 % during the forecast period. IBM (US), Okta (US), SAP (US), Microsoft (US), Ping Identity (US), Thales (France), Broadcom (US), AWS (US), Salesforce (US), OpenText (Canada), Akamai Technology (US), Deloitte (UK), HID Global (US), CyberArk (US), Nevis Security (Switzerland), Simeio Solutions (US), Ubisecure (Finland), OneLogin (US), SecureAuth (US), LoginRadius (Canada), IDology (US), Omada Identity (Denmark), WSO2 (US), WidasConcepts (Germany), FusionAuth (US), Transmit Security (Israel), IDnow (Germany), MiniOrange (US), Strivacity (US) are the key players and other players in the CIAM market.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028
The global veterinary API market, valued at US$8.0 billion in 2022, stood at US$8.5 billion in 2023 and is projected to advance at a resilient CAGR of 6.9% from 2023 to 2028, culminating in a forecasted valuation of US$11.9 billion by the end of the period. The veterinary active pharmaceutical ingredient (API) market is growing due to various factors, including the increased occurrence of transboundary and zoonotic diseases, a rise in the global animal population and pet ownership, and the implementation of improved disease control and prevention measures.
- Published: June 2023
- Price: $ 4950
- TOC Available:
-
APAC Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The APAC injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period.
- Published: July 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
